How Much Did Bonumose Raise?
Funding & Key Investors

Bonumose has successfully secured a significant capital infusion, bringing its cumulative financing to $12.5M. This latest major strategic investment of $9M underscores the company's pivotal role in the food-tech sector. By leveraging proprietary enzymatic technology, the firm is positioned to disrupt the traditional sweetener market, transitioning from early-stage development to a robust enterprise-level scaling phase.

What is Bonumose?

Bonumose
ManufacturingFood & BeverageBusiness Services

Bonumose, Inc. operates at the intersection of biotechnology and food science, specializing in the production of tagatose—a rare, naturally occurring sugar that mimics the sensory profile of sucrose while maintaining a low glycemic index and reduced caloric density. The company's core value proposition lies in its ability to democratize access to healthy sugar alternatives, enabling large-scale food and beverage manufacturers to reformulate products without sacrificing consumer taste preferences. Through its innovative enzymatic platform, Bonumose is not only addressing the global demand for healthier ingredients but is also establishing a scalable infrastructure for the mass-market adoption of functional food components.

How much funding has Bonumose raised?

Bonumose has raised a total of $12.4M across 3 funding rounds:

2017

Series A

$3.3M

2020

Debt

$150K

2021

Other Financing Round

$9M

Series A (2017): $3.3M with participation from iSELECT FUND and Argonautic Ventures

Debt (2020): $150K led by PPP

Other Financing Round (2021): $9M, investors not publicly disclosed

Key Investors in Bonumose

iSELECT FUND

A venture capital firm focused on early-stage investments in life sciences and agricultural technology sectors.

Argonautic Ventures

An investment group specializing in high-growth technology companies with a focus on sustainable and scalable business models.

PPP

Public-Private Partnership

What's next for Bonumose?

With the recent influx of capital, Bonumose is poised to accelerate its manufacturing capabilities and expand its commercial footprint within the global food supply chain. The strategic focus will likely shift toward optimizing production yields for rare sugars and deepening partnerships with major CPG entities seeking to meet evolving health-conscious consumer mandates. As the company matures, the emphasis will remain on maintaining cost-competitiveness while scaling its enzymatic technology to meet the rigorous demands of industrial-scale food production, effectively bridging the gap between laboratory innovation and widespread market integration.

See full Bonumose company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Industrial Machinery & EquipmentManufacturingPlastic, Packaging & Containers
Building MaterialsManufacturingIndustrial Machinery & Equipment
Building MaterialsManufacturingFurnitureArchitecture, Engineering & DesignConstruction ManagementConstruction

Frequently Asked Questions Regarding Bonumose Financial Insights

What are the most recent funding rounds that Bonumose has completed, and what were the funding rounds?
Bonumose has recently completed 3 funding rounds: Other Financing Round on Mar 10, 2021, Debt on Apr 14, 2020, Series A on Dec 22, 2017.
What is the total amount of funding Bonumose has raised to date?
Bonumose has raised a total of $12.4M in funding to date.
How many funding rounds has Bonumose completed?
Bonumose has completed 3 funding rounds.
How much funding did Bonumose raise in its most recent funding round?
Bonumose raised $9M in its most recent funding round.
Which was the largest funding round in Bonumose's history?
The largest funding round in Bonumose's history was $9M.
See more information about Bonumose